La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Neurofilament cytoskeleton disruption does not modify accumulation of trophic factor mRNA

Identifieur interne : 000289 ( France/Analysis ); précédent : 000288; suivant : 000290

Neurofilament cytoskeleton disruption does not modify accumulation of trophic factor mRNA

Auteurs : Patrick Robert [France] ; Alan C. Peterson [Canada] ; Joël Eyer [France]

Source :

RBID : ISTEX:1E5C311F6EDB5217BA9DD1244AECCE22D25DCBAE

English descriptors

Abstract

Previously we described a transgenic mouse model in which neurofilaments are sequestered in neuronal cell bodies and withheld from the axonal compartment. This model and other transgenic models with disrupted neurofilaments are used widely to investigate the role of the neurofilament cytoskeleton in normal neurons and in inherited or acquired diseases. To interpret such studies, it is important to establish whether the maldistribution of neurofilaments has major secondary consequences on the cell biology of the affected neurons. Notably, multiple perturbations of the nervous system simultaneously affect both the neuronal cytoskeleton and neurotrophin expression. To determine whether the expression of neurotrophic factors or their receptors is perturbed by a primary disruption in neurofilaments, we compared the accumulated mRNA levels for ciliary neuroptrophic factor (CNTF), nerve growth factor, neurotrophin 3, and the α CNTF receptor in mature transgenic mice and their littermate controls. Consistently with the prolonged survival of neurons expressing atypical or abnormally distributed neurofilaments, no obvious changes were observed for any of the mRNA species examined. J. Neurosci. Res. 64:487–492, 2001. © 2001 Wiley‐Liss, Inc.

Url:
DOI: 10.1002/jnr.1100


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:1E5C311F6EDB5217BA9DD1244AECCE22D25DCBAE

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Neurofilament cytoskeleton disruption does not modify accumulation of trophic factor mRNA</title>
<author>
<name sortKey="Robert, Patrick" sort="Robert, Patrick" uniqKey="Robert P" first="Patrick" last="Robert">Patrick Robert</name>
</author>
<author>
<name sortKey="Peterson, Alan C" sort="Peterson, Alan C" uniqKey="Peterson A" first="Alan C." last="Peterson">Alan C. Peterson</name>
</author>
<author>
<name sortKey="Eyer, Joel" sort="Eyer, Joel" uniqKey="Eyer J" first="Joël" last="Eyer">Joël Eyer</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:1E5C311F6EDB5217BA9DD1244AECCE22D25DCBAE</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1002/jnr.1100</idno>
<idno type="url">https://api-v5.istex.fr/document/1E5C311F6EDB5217BA9DD1244AECCE22D25DCBAE/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002727</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002727</idno>
<idno type="wicri:Area/Istex/Curation">002727</idno>
<idno type="wicri:Area/Istex/Checkpoint">001025</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001025</idno>
<idno type="wicri:doubleKey">0360-4012:2001:Robert P:neurofilament:cytoskeleton:disruption</idno>
<idno type="wicri:Area/Main/Merge">003678</idno>
<idno type="wicri:Area/Main/Curation">003197</idno>
<idno type="wicri:Area/Main/Exploration">003197</idno>
<idno type="wicri:Area/France/Extraction">000289</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Neurofilament cytoskeleton disruption does not modify accumulation of trophic factor mRNA</title>
<author>
<name sortKey="Robert, Patrick" sort="Robert, Patrick" uniqKey="Robert P" first="Patrick" last="Robert">Patrick Robert</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Neurobiologie et Transgénèse, UPRES‐EA3143, INSERM E9928, Centre Hospitalier Universitaire, Angers</wicri:regionArea>
<placeName>
<region type="region">Pays de la Loire</region>
<region type="old region">Pays de la Loire</region>
<settlement type="city">Angers</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Peterson, Alan C" sort="Peterson, Alan C" uniqKey="Peterson A" first="Alan C." last="Peterson">Alan C. Peterson</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Molecular Oncology Group, McGill University, Royal Victoria Hospital, Montreal, Quebec</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Eyer, Joel" sort="Eyer, Joel" uniqKey="Eyer J" first="Joël" last="Eyer">Joël Eyer</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Neurobiologie et Transgénèse, UPRES‐EA3143, INSERM E9928, Centre Hospitalier Universitaire, Angers</wicri:regionArea>
<placeName>
<region type="region">Pays de la Loire</region>
<region type="old region">Pays de la Loire</region>
<settlement type="city">Angers</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM Laboratoire de Neurobiologie et Transgénèse, UPRES‐EA3143, CHU, 49033 Angers</wicri:regionArea>
<wicri:noRegion>49033 Angers</wicri:noRegion>
<wicri:noRegion>49033 Angers</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Neuroscience Research</title>
<title level="j" type="abbrev">J. Neurosci. Res.</title>
<idno type="ISSN">0360-4012</idno>
<idno type="eISSN">1097-4547</idno>
<imprint>
<publisher>John Wiley & Sons, Inc.</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2001-06-01">2001-06-01</date>
<biblScope unit="volume">64</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="487">487</biblScope>
<biblScope unit="page" to="492">492</biblScope>
</imprint>
<idno type="ISSN">0360-4012</idno>
</series>
<idno type="istex">1E5C311F6EDB5217BA9DD1244AECCE22D25DCBAE</idno>
<idno type="DOI">10.1002/jnr.1100</idno>
<idno type="ArticleID">JNR1100</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0360-4012</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>NFHLacZ transgenic mice</term>
<term>mRNA</term>
<term>microtubules</term>
<term>neurofilaments</term>
<term>neurotrophins</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Previously we described a transgenic mouse model in which neurofilaments are sequestered in neuronal cell bodies and withheld from the axonal compartment. This model and other transgenic models with disrupted neurofilaments are used widely to investigate the role of the neurofilament cytoskeleton in normal neurons and in inherited or acquired diseases. To interpret such studies, it is important to establish whether the maldistribution of neurofilaments has major secondary consequences on the cell biology of the affected neurons. Notably, multiple perturbations of the nervous system simultaneously affect both the neuronal cytoskeleton and neurotrophin expression. To determine whether the expression of neurotrophic factors or their receptors is perturbed by a primary disruption in neurofilaments, we compared the accumulated mRNA levels for ciliary neuroptrophic factor (CNTF), nerve growth factor, neurotrophin 3, and the α CNTF receptor in mature transgenic mice and their littermate controls. Consistently with the prolonged survival of neurons expressing atypical or abnormally distributed neurofilaments, no obvious changes were observed for any of the mRNA species examined. J. Neurosci. Res. 64:487–492, 2001. © 2001 Wiley‐Liss, Inc.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
<li>France</li>
</country>
<region>
<li>Pays de la Loire</li>
<li>Québec</li>
</region>
<settlement>
<li>Angers</li>
<li>Montréal</li>
</settlement>
<orgName>
<li>Université McGill</li>
</orgName>
</list>
<tree>
<country name="France">
<region name="Pays de la Loire">
<name sortKey="Robert, Patrick" sort="Robert, Patrick" uniqKey="Robert P" first="Patrick" last="Robert">Patrick Robert</name>
</region>
<name sortKey="Eyer, Joel" sort="Eyer, Joel" uniqKey="Eyer J" first="Joël" last="Eyer">Joël Eyer</name>
<name sortKey="Eyer, Joel" sort="Eyer, Joel" uniqKey="Eyer J" first="Joël" last="Eyer">Joël Eyer</name>
</country>
<country name="Canada">
<region name="Québec">
<name sortKey="Peterson, Alan C" sort="Peterson, Alan C" uniqKey="Peterson A" first="Alan C." last="Peterson">Alan C. Peterson</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000289 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000289 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:1E5C311F6EDB5217BA9DD1244AECCE22D25DCBAE
   |texte=   Neurofilament cytoskeleton disruption does not modify accumulation of trophic factor mRNA
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022